Formulation and characterization of cellulose acetate butyrate nanoparticles loaded with nevirapine for HIV treatment

Gupta, 2010, Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting, Adv. Drug Deliv. Rev., 62, 478, 10.1016/j.addr.2009.11.018

Gunaseelan, 2010, Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs, Adv. Drug Deliv. Rev., 62, 518, 10.1016/j.addr.2009.11.021

Ogunwuyi, 2016, Antiretroviral drugs-loaded nanoparticles fabricated by dispersion polymerization with potential for HIV/AIDS treatment, J. Infect. Dis., 9, 21

Ahammed, 2017, Development and in vivo evaluation of functionalized ritonavir proliposomes for lymphatic targeting, Life Sci., 183, 11, 10.1016/j.lfs.2017.06.022

Vyas, 2006, Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites, Expet Opin. Drug Deliv., 3, 613, 10.1517/17425247.3.5.613

Shegokar, 2011, Stavudine entrapped lipid nanoparticles for targeting lymphatic HIV reservoirs, Pharmazie, 66, 264

Koppensteiner, 2012, Macrophages and their relevance in human immunodeficiency virus type I infection, Retrovirology, 9, 82, 10.1186/1742-4690-9-82

Merino, 2017, Role of Monocyte/macrophages during Hiv/Siv infection in adult and pediatric acquired immune deficiency syndrome, Front. Immunol., 8, 1693, 10.3389/fimmu.2017.01693

Dutta, 2007, Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro, J. Drug Target., 15, 89, 10.1080/10611860600965914

Löbenberg, 1998, Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after iv injection to rats, J. Contr. Release, 50, 21, 10.1016/S0168-3659(97)00105-3

Dou, 2006, Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery, Blood, 108, 2827, 10.1182/blood-2006-03-012534

Jain, 2013, Targeted drug delivery to macrophages, Expet Opin. Drug Deliv., 10, 353, 10.1517/17425247.2013.751370

Kaur, 2008, Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: in vitro and in vivo evaluation, Acta Pharm., 58, 61, 10.2478/v10007-007-0045-1

Van de Ven, 2012, Intracellular drug delivery in Leishmania-infected macrophages: evaluation of saponin-loaded PLGA nanoparticles, J. Drug Target., 20, 142, 10.3109/1061186X.2011.595491

Sandhya, 2018, Amphotericin B loaded sulphonated chitosan nanoparticles for targeting macrophages to treat intracellular Candida glabrata infections, Int. J. Biol. Macromol., 110, 133, 10.1016/j.ijbiomac.2018.01.028

Kuo, 2011, Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers, Colloids Surf., B, 83, 299, 10.1016/j.colsurfb.2010.11.037

Ramana, 2010, Development of a liposomal nanodelivery system for nevirapine, J. Biomed. Sci., 17, 57, 10.1186/1423-0127-17-57

Jelvehgari, 2009, Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method, Arch Pharm. Res. (Seoul), 32, 1019, 10.1007/s12272-009-1707-y

Rokhade, 2007, Preparation and evaluation of cellulose acetate butyrate and poly (ethylene oxide) blend microspheres for gastroretentive floating delivery of repaglinide, J. Appl. Polym. Sci., 105, 2764, 10.1002/app.26456

Li, 2009, PEG–PLA diblock copolymer micelle-like nanoparticles as all-trans-retinoic acid Carrier: in vitro and in vivo characterizations, Nanotechnology, 20, 055106, 10.1088/0957-4484/20/5/055106

Joshi, 2016, Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles, Drug Deliv, 23, 3492, 10.1080/10717544.2016.1199605

Alizadeh, 2018, Prolonged injectable formulation of Nafarelin using in situ gel combination delivery system, Pharmaceut. Dev. Technol., 23, 132, 10.1080/10837450.2017.1321662

Bahari Javan, 2016, Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide, J. Microencapsul., 33, 460, 10.1080/02652048.2016.1208296

Mainardes, 2005, PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution, Int. J. Pharm., 290, 137, 10.1016/j.ijpharm.2004.11.027

Emami, 2015, Formulation and optimization of celecoxib-loaded PLGA nanoparticles by the Taguchi design and their in vitro cytotoxicity for lung cancer therapy, Pharmaceut. Dev. Technol., 20, 791, 10.3109/10837450.2014.920360

Quintanar-Guerrero, 1996, Influence of stabilizing agents and preparative variables on the formation of poly (D, L-lactic acid) nanoparticles by an emulsification-diffusion technique, Int. J. Pharm., 143, 133, 10.1016/S0378-5173(96)04697-2

Hadipour Moghaddam, 2013, Development of a nano-micro Carrier system for sustained pulmonary delivery of clarithromycin, Powder Technol., 239, 478, 10.1016/j.powtec.2013.02.025

Varshosaz, 2014, Novel lectin-modified poly (ethylene-co-vinyl acetate) mucoadhesive nanoparticles of carvedilol: preparation and in vitro optimization using a two-level factorial design, Pharmaceut. Dev. Technol., 19, 605, 10.3109/10837450.2013.819011

Budhian, 2007, Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content, Int. J. Pharm., 336, 367, 10.1016/j.ijpharm.2006.11.061

Awotwe-Otoo, 2012, Evaluation of anticancer drug-loaded nanoparticle characteristics by nondestructive methodologies, AAPS PharmSciTech, 13, 611, 10.1208/s12249-012-9782-7

Varshosaz, 2010, Production and optimization of valproic acid nanostructured lipid carriers by the Taguchi design, Pharmaceut. Dev. Technol., 15, 89, 10.3109/10837450903013568

Duxfield, 2016, Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery, Pharmaceut. Dev. Technol., 21, 172, 10.3109/10837450.2015.1091839

Varshosaz, 2017, Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles, Res Pharm Sci, 12, 222, 10.4103/1735-5362.207203

Varshosaz, 2018, Development and in vitro/in vivo evaluation of HPMC/chitosan gel containing simvastatin loaded self-assembled nanomicelles as a potent wound healing agent, Drug Dev. Ind. Pharm., 44, 276, 10.1080/03639045.2017.1391832

Musumeci, 2006, PLA/PLGA nanoparticles for sustained release of docetaxel, Int. J. Pharm., 325, 172, 10.1016/j.ijpharm.2006.06.023

Zhang, 2010, A novel paclitaxel-loaded poly (εcaprolactone)/poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment, Acta Biomater., 6, 2045, 10.1016/j.actbio.2009.11.035

Yadav, 2015, Development of novel docetaxel phospholipid nanoparticles for intravenous administration: quality by design approach, AAPS PharmSciTech, 16, 855, 10.1208/s12249-014-0274-9

Wang, 2012, Alpha-tocopheryl polyethylene glycol succinate-emulsified poly (lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro, Nanotechnology, 23, 495103, 10.1088/0957-4484/23/49/495103

Chaudhari, 2012, Opsonization, biodistribution, cellular uptake and apoptosis study of PEGylated PBCA nanoparticle as potential drug delivery Carrier, Pharm. Res. (N. Y.), 29, 53, 10.1007/s11095-011-0510-x

Park, 2010, In vivo and in vitro anti-cancer activities and enhanced cellular uptakes of EGF fragment decorated doxorubicin nano-aggregates, Int. J. Pharm., 383, 178, 10.1016/j.ijpharm.2009.08.039

Lv, 2013, Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy, Acta Biomater., 9, 9330, 10.1016/j.actbio.2013.08.015